Julie Garner

VP, Government Affairs and Patient Advocacy

Julie leads Government Affairs and Patient Advocacy with a collaborative, community-driven approach that advances public policy and promotes access to innovation. With more than 20 years of experience in the biopharmaceutical and healthcare sectors, she has consistently championed initiatives that drive meaningful change and improve patient outcomes.

Julie’s career is rooted in government affairs and public policy, where she has built a reputation for developing and executing strategies that foster cross-sector partnerships and deliver measurable results. Most recently, she served as Vice President of Government Affairs and Public Policy at Sage Therapeutics, where she spearheaded key initiatives to improve healthcare delivery, with a focus on maternal mental health. Her previous leadership roles at AstraZeneca and MedImmune further reflect her deep expertise in advocacy and policy development.

Julie holds a Bachelor of Arts in Political Science from Salisbury University.

Paul Summergrad, MD

Professor of Psychiatry and Medicine at Tufts University School of Medicine and Chairman Emeritus of the department of psychiatry at Tufts Medical Center

Nzinga Harrison, MD

Co-Founder & Chief Medical Officer, Eleanor Health

Carol Vallone

Chair of the Board of Directors, Member of Compensation Committee, Member of Audit Committee

Andreas Krebs

Vice Chair of the Board of Directors, Member of Nomination & Governance Committee, Member of Audit Committee

David Gryska

Board Director, Chair of Audit Committee

Roger Crystal, MD

Board Director, Chair of Nomination & Governance Committee, Member of Compensation Committee

Robert Barrow

Chief Executive Officer and Board Director

Suzanne Bruhn, PhD

Board Director, Chair of Compensation Committee, Member of Nomination & Governance Committee

Daniel Karlin, MD, MA

Chief Medical Officer

Stephanie Fagan, MS

Chief Corporate Affairs Officer

Gregg Pratt, PhD

Chief Regulatory and Quality Assurance Officer

Brandi Roberts, CPA

Chief Financial Officer

Mark Sullivan, JD

Chief Legal Officer and Corporate Secretary

Matt Wiley

Chief Commercial Officer

Robert Malenka, MD, PhD

Chairman of the Scientific Advisory Board, Nancy Friend Pritzker Professor in Psychiatry and Behavioral Sciences at Stanford University

Peter Bergethon, MD

Member, Scientific Advisory Board VP, Head of Quantitative & Clinical Technologies, Biogen, Inc.

Robert Dworkin, PhD

Professor of Anesthesiology and Perioperative Medicine, Neurology, and Psychiatry at University of Rochester

Maurizio Fava, MD

Psychiatrist-in-Chief of the Massachusetts General Hospital (MGH)

Peter Mack, PhD

SVP, Pharmaceutical Development and Operations

Beth Calitri

VP, Corporate Communications

Phong Duong, PharmD

VP, Market Access and Health Economics

Julie Garner

VP, Government Affairs and Patient Advocacy

Lysa Triantafillou

VP, Quality Assurance

Maria Oquendo, MD, PhD

Ruth Meltzer Professor and Chairman of Psychiatry at University of Pennsylvania, Psychiatrist-in-Chief at the Hospital of the University of Pennsylvania

Matthias Liechti, MD, PhD

Scientific Collaborator & Advisor

Kim PC Kuypers, PhD

Scientific Collaborator & Advisor

Peter Gasser, MD

Clinical Advisor
×

Thanks for visiting!

You are leaving MindMed and will be automatically redirected to ${url} in a moment.

Change your mind?

Return to Mindmed